Medicare Enrolled
Dr. Alex Kawana, M.D
Optician · West Hollywood, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Kawana from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Kawana?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Kawana
Dr. Alex Kawana is an optician specialist in West Hollywood, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Kawana performed 13,380 Medicare services across 1,768 unique beneficiaries.
Between the years covered by Open Payments, Dr. Kawana received a total of $4,869 from 46 pharmaceutical and/or device companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Kawana is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 7% volume in CA
$4,869 industry payments
Medicare Practice Summary
Medicare Utilization ↗13,380
Medicare services
Top 7% in CA for optician
1,768
Unique beneficiaries
$23
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~704 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 1,920 | $14 | $33 |
| Unclassified drug A medication that does not fit into standard HCPCS or CPT classification categories. |
1,120 | $20 | $33 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
1,055 | $11 | $50 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
888 | $8 | $25 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
873 | $8 | $30 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
817 | $10 | $30 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
773 | $76 | $120 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
642 | $58 | $150 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
630 | $1 | $35 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
593 | $34 | $100 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
588 | $104 | $175 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
504 | $29 | $100 |
| Magnesium sulfate injection, per 500 mg An injection of magnesium sulfate administered in 500 mg increments. |
471 | $1 | $5 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
449 | $12 | $60 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
245 | $18 | $50 |
| Normal saline infusion, 250 cc Administration of 250 cubic centimeters of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater fluid. |
213 | $0 | $20 |
| Lactate dehydrogenase (LDH) level test A blood test that measures the amount of lactate dehydrogenase, an enzyme found in many body tissues. It helps assess tissue damage or disease. |
139 | $6 | $25 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
129 | $5 | $15 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
111 | $26 | $125 |
| Iron dextran injection, 50 mg An injection containing 50 mg of iron dextran administered to the patient. |
110 | $13 | $50 |
| Carcinoembryonic antigen (CEA) level test A blood test that measures the level of carcinoembryonic antigen (CEA) protein. This test is used to monitor certain types of cancer. |
93 | $19 | $65 |
| Ferritin level test (iron stores) A blood test that measures the level of ferritin, a protein that stores iron in the body. |
82 | $13 | $50 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
72 | $1 | $10 |
| Immunoglobulin level test A blood test that measures the level of gammaglobulins, which are immune system proteins. |
67 | $9 | $20 |
| Iron level test | 63 | $6 | $20 |
| Iron binding capacity test A blood test that measures the amount of iron in the blood and the blood's ability to bind and transport iron. |
62 | $9 | $20 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
60 | $29 | $60 |
| Immunologic analysis for detection of tumor antigen, quantitative; ca 15-3 | 55 | $20 | $60 |
| Magnesium level test A blood test to measure the amount of magnesium in your body. This helps check for magnesium deficiency or excess. |
52 | $7 | $20 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
50 | $8 | $30 |
| New patient office visit, complex (60-74 min) | 40 | $180 | $300 |
| Lipid panel (cholesterol and triglycerides) A blood test that measures cholesterol and triglyceride levels. |
36 | $13 | $40 |
| LDL cholesterol level test A blood test that measures the amount of low-density lipoprotein (LDL) cholesterol in your blood. LDL is often referred to as "bad" cholesterol. |
36 | $10 | $20 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
36 | $5 | $10 |
| Vitamin B-12 level test A blood test that measures the amount of vitamin B-12 in your body. |
33 | $15 | $30 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
32 | $16 | $30 |
| Hemoglobin A1c test (diabetes monitoring) A blood test that measures your average blood sugar levels over the past two to three months. |
28 | $10 | $20 |
| Thyroxine (T4) level test A blood test that measures the total amount of thyroxine, a thyroid hormone, in your body. |
28 | $7 | $15 |
| Thyroid hormone evaluation A blood test to measure the levels of thyroid hormones in the body. This evaluation helps assess how well the thyroid gland is functioning. |
28 | $6 | $50 |
| Erythrocyte sedimentation rate (ESR) test A blood test that measures how quickly red blood cells settle in a test tube to detect inflammation in the body. This specific method is performed manually rather than using an automated machine. |
28 | $4 | $10 |
| Free T3 thyroid hormone test A blood test that measures the level of free triiodothyronine (T3) hormone in your body. This helps assess how well your thyroid gland is functioning. |
27 | $17 | $40 |
| High-sensitivity C-reactive protein test A blood test that measures high-sensitivity C-reactive protein to detect infection or inflammation. |
27 | $13 | $25 |
| PSA test (prostate cancer screening) | 25 | $18 | $40 |
| Folic acid level test A blood test that measures the amount of folic acid in the serum. |
21 | $14 | $40 |
| Manual urinalysis with microscopic examination A urine test performed manually without automated equipment. The sample is examined under a microscope to check for abnormalities. |
17 | $4 | $10 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
12 | $30 | $37 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
17.5% high complexity
27.0% medium
55.5% routine
Industry Payment Transparency
Open Payments through 2024 ↗$4,869
Total received (2018-2024)
Avg $696/year across 7 years
Top 24% in CA for optician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
46
Companies
185
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$4,697 (96.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$171 (3.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$236
2023
$1,588
2022
$1,418
2021
$452
2020
$516
2019
$157
2018
$501
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
E.R. Squibb & Sons, L.L.C.
$130
ViiV Healthcare Company
$27
Janssen Biotech, Inc.
$26
Lilly USA, LLC
$21
Takeda Pharmaceuticals U.S.A., Inc.
$16
ADC Therapeutics America, Inc.
$16
Top 3 companies account for 77.6% of 2024 payments
All-time payments by company (2018-2024) ›
E.R. Squibb & Sons, L.L.C.
$885
Amgen Inc.
$750
AstraZeneca Pharmaceuticals LP
$487
Janssen Biotech, Inc.
$355
Daiichi Sankyo Inc.
$182
Global Blood Therapeutics, Inc.
$174
Bayer HealthCare Pharmaceuticals Inc.
$164
Takeda Pharmaceuticals U.S.A., Inc.
$141
Genentech USA, Inc.
$117
Merck Sharp & Dohme LLC
$114
Horizon Therapeutics plc
$104
Bayer Healthcare Pharmaceuticals Inc.
$90
Lilly USA, LLC
$89
PFIZER INC.
$88
ViiV Healthcare Company
$85
NOVARTIS PHARMACEUTICALS CORPORATION
$66
Rigel Pharmaceuticals, Inc.
$65
Karyopharm Therapeutics Inc.
$63
Novartis Pharmaceuticals Corporation
$62
Seagen Inc.
$53
Alexion Pharmaceuticals, Inc.
$52
EMD Serono, Inc.
$52
Eisai Inc.
$47
Amneal Pharmaceuticals LLC
$42
Novo Nordisk Inc
$41
GENZYME CORPORATION
$36
Merck Sharp & Dohme Corporation
$33
GlaxoSmithKline, LLC.
$30
Regeneron Healthcare Solutions, Inc.
$29
Pharmacyclics LLC, an AbbVie Company
$29
Pharmacosmos Therapeutics Inc.
$28
Organon LLC
$25
Celgene Corporation
$24
Gilead Sciences, Inc.
$24
AKEBIA THERAPEUTICS INC
$24
Xeris Pharmaceuticals, Inc.
$24
Travere Therapeutics, Inc.
$23
Clovis Oncology, Inc.
$22
Myriad Genetic Laboratories, Inc.
$22
Biogen, Inc.
$21
Astellas Pharma US Inc
$19
Pharmacyclics LLC, An AbbVie Company
$19
Octapharma USA, Inc.
$19
Kite Pharma, Inc.
$17
ADC Therapeutics America, Inc.
$16
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$15
Top 3 companies account for 43.6% of all-time payments
Associated products mentioned in payments ›
ALUNBRIG · APRETUDE · AVASTIN · Auryxia · BELSOMRA · BLENREP · CALQUENCE · DARZALEX · ELIQUIS · ENHERTU · ERLEADA · EVENITY · EXKIVITY · Enhertu · FARXIGA · FRUZAQLA · GVOKE PFS · ICLUSIG · IMBRUVICA · IMFINZI · Imbruvica · JANUVIA · KANJINTI · KEYTRUDA · KRYSTEXXA · Kerendia · LIBTAYO · LOKELMA · Lenvima · MONOFERRIC · MOUNJARO · Neulasta · Nplate · Nubeqa · ONTRUZANT · OPDIVO · OXBRYTA · PANZYGA · PIQRAY · PROMACTA · REBLOZYL · Rubraca · Rybelsus · SCEMBLIX · TECENTRIQ · TUKYSA · TYSABRI · Tavalisse · Trodelvy · ULTOMIRIS · VENCLEXTA · VERZENIO · VPRIV · Vectibix · Wegovy · XGEVA · XIFAXAN · XPOVIO · Xtandi · Yescarta · myRisk
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (96%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Opticians within 10 mi
1,540
Per 100K population
15.6
County median income
$87,760
Nearest hospital
CEDARS-SINAI MEDICAL CENTER
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Kawana is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Kawana experienced with denosumab injection (prolia/xgeva)?
Based on Medicare claims data, Dr. Kawana performed 1,920 denosumab injection (prolia/xgeva) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Kawana receive payments from pharmaceutical companies?
Yes. Dr. Kawana received a total of $4,869 from 46 companies across 185 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Kawana's costs compare to other opticians in West Hollywood?
Dr. Kawana's average Medicare payment per service is $23. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Kawana) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in West Hollywood
Browse opticians in West Hollywood ranked by procedure volume and transparency data.
Highest volume
Top Opticians in CA
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in CA
Which CA opticians receive the most from drug and device companies.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology